Bandhan Healthcare Fund - Regular Plan - IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 10-11-2025
AUM:
₹ 290.55 Cr
Expense Ratio
2.43%
Benchmark
BSE Healthcare TRI
ISIN
INF194KB1KD0
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Viraj Kulkarni, Brijesh Shah, Ritika Behera, Gaurav Satra
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Bandhan Healthcare Fund - Regular Plan - IDCW | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
10.147
Last change
0.05 (0.4632%)
Fund Size (AUM)
₹ 290.55 Cr
Performance
1.92% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realised.
Fund Manager
Viraj Kulkarni, Brijesh Shah, Ritika Behera, Gaurav Satra
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 9.34 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 8.67 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.61 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 6.92 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.76 |
| Dr. Reddys Laboratories Ltd | 5.92 |
| JB Chemicals & Pharmaceuticals Limited | 4.57 |
| Triparty Repo TRP_040526 | 4.35 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 3.48 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 2.91 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 93.2 |
| Financial Services | 2.4 |
| Information Technology | 0.28 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Bandhan Healthcare Fund Reg Plan IDCW | 0.0 |